SPL 1.05% 9.6¢ starpharma holdings limited

Bell Potter raises target to $2.20, page-5

  1. 2,065 Posts.
    lightbulb Created with Sketch. 304
    From the BP report summary --

    . COVID-19 has impacted recruitment in Phase 2 DEP-trials,
    however sites have reinitiated
    recruitment (London sites a bit slower than regional UK sites) and at this
    stage results from all the trials are expected within the next 6-7 months,
    which would serve as significant re-rating catalysts for the stock.

    I would suggest this info has come from SPL HQ
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.001(1.05%)
Mkt cap ! $39.58M
Open High Low Value Volume
9.6¢ 9.6¢ 9.5¢ $11.41K 118.9K

Buyers (Bids)

No. Vol. Price($)
1 239840 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.